Mysore Petro Chemicals Limited (BOM:506734)
India · Delayed Price · Currency is INR 165.35
-0.62 (-0.37%)
At close: Aug 21, 2026
Mysore Petro Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 563.93 | 522.11 | 334.79 | 257.99 | 184.14 | 209 | |
Revenue Growth | 86.45% | 55.95% | 29.77% | 40.10% | -11.89% | -8.50% |
Cost of Revenue | 541.08 | 500.74 | 319.62 | 247.35 | 176.19 | 198.88 |
Gross Profit | 22.86 | 21.37 | 15.16 | 10.64 | 7.95 | 10.12 |
Selling, General & Admin | 21.49 | 21.53 | 42.44 | 26.79 | 30.63 | 23.9 |
Other Operating Expenses | -6.43 | -4.49 | 6.06 | 2.63 | 12.53 | -11.8 |
Operating Expenses | 18.57 | 20.54 | 52.18 | 33.89 | 47.44 | 18.05 |
Operating Income | 4.29 | 0.83 | -37.02 | -23.25 | -39.48 | -7.92 |
Interest Expense | -0.68 | -0.72 | -0.66 | -1.08 | -5.08 | -2.53 |
Interest & Investment Income | 8.99 | 8.99 | 14.53 | 15.19 | 8.34 | 19.74 |
Earnings From Equity Investments | 108.04 | 2.94 | 143.81 | 52.28 | 264.62 | 349.94 |
Currency Exchange Gain (Loss) | 0.81 | 0.81 | 7.88 | -0.49 | - | - |
Other Non Operating Income (Expenses) | 20.17 | 0.09 | 0.05 | 0.75 | -0.42 | -0.03 |
EBT Excluding Unusual Items | 141.62 | 12.94 | 128.59 | 43.39 | 227.98 | 359.19 |
Gain (Loss) on Sale of Investments | -6.61 | -6.61 | 53.86 | 80.37 | 41.04 | 66.7 |
Gain (Loss) on Sale of Assets | 1.34 | 1.34 | - | 0.28 | - | - |
Other Unusual Items | - | - | 2.19 | - | - | - |
Pretax Income | 136.35 | 7.67 | 184.65 | 124.03 | 269.02 | 425.89 |
Income Tax Expense | 28.67 | -0.44 | 43.2 | 24.88 | 61.8 | 98.97 |
Earnings From Continuing Operations | 107.68 | 8.11 | 141.44 | 99.15 | 207.22 | 326.92 |
Earnings From Discontinued Operations | - | - | -111.01 | -24.44 | - | - |
Net Income | 107.68 | 8.11 | 30.43 | 74.71 | 207.22 | 326.92 |
Net Income to Common | 107.68 | 8.11 | 30.43 | 74.71 | 207.22 | 326.92 |
Net Income Growth | - | -73.34% | -59.27% | -63.94% | -36.61% | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Change | -0.14% | - | - | - | - | - |
EPS (Basic) | 16.37 | 1.23 | 4.62 | 11.35 | 31.48 | 49.66 |
EPS (Diluted) | 16.36 | 1.23 | 4.62 | 11.35 | 31.48 | 49.66 |
EPS Growth | - | -73.37% | -59.30% | -63.95% | -36.61% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 82.9 | -43.2 | -184.8 | -32.36 | -29.6 |
Free Cash Flow Per Share | - | 12.59 | -6.56 | -28.07 | -4.92 | -4.50 |
Dividend Per Share | - | 2.000 | 2.000 | 2.500 | 2.500 | 2.500 |
Dividend Growth | - | 0% | -20.00% | 0% | 0% | 25.00% |
Gross Margin | 4.05% | 4.09% | 4.53% | 4.12% | 4.32% | 4.84% |
Operating Margin | 0.76% | 0.16% | -11.06% | -9.01% | -21.44% | -3.79% |
Profit Margin | 19.10% | 1.55% | 9.09% | 28.96% | 112.53% | 156.42% |
Free Cash Flow Margin | - | 15.88% | -12.90% | -71.63% | -17.57% | -14.16% |
EBITDA | 7.21 | 3.83 | -33.71 | -18.78 | -35.21 | -1.98 |
EBITDA Margin | 1.28% | 0.73% | -10.07% | -7.28% | -19.12% | -0.95% |
D&A For EBITDA | 2.92 | 3 | 3.31 | 4.48 | 4.27 | 5.94 |
EBIT | 4.29 | 0.83 | -37.02 | -23.25 | -39.48 | -7.92 |
EBIT Margin | 0.76% | 0.16% | -11.06% | -9.01% | -21.44% | -3.79% |
Effective Tax Rate | 21.02% | - | 23.40% | 20.06% | 22.97% | 23.24% |
Revenue as Reported | 667.18 | 605.28 | 433.7 | 379.89 | 270.04 | 321 |